• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Comparison of common acute respiratory infection case definitions for identification of hospitalized influenza cases at a population-base

tetano

Editor, Senior Moderator
PLoS One


. 2021 Mar 25;16(3):e0248563.
doi: 10.1371/journal.pone.0248563. eCollection 2021.
Comparison of common acute respiratory infection case definitions for identification of hospitalized influenza cases at a population-based surveillance site in Egypt


Emily Rowlinson[SUP] 1 [/SUP], Lisa Peters[SUP] 1 [/SUP], Adel Mansour[SUP] 1 [/SUP], Hoda Mansour[SUP] 1 [/SUP], Nahed Azazzy[SUP] 2 [/SUP], Mayar Said[SUP] 1 [/SUP], Sahar Samy[SUP] 2 [/SUP], Eman Abbas[SUP] 2 [/SUP], Hanaa Abu Elsood[SUP] 2 [/SUP], Manal Fahim[SUP] 2 [/SUP], Alaa Eid[SUP] 2 [/SUP], Erik Reaves[SUP] 3 [/SUP], Chris Van Beneden[SUP] 3 [/SUP], Sarah Hamid[SUP] 1 [/SUP], Sonja Olsen[SUP] 3 [/SUP], Julia Fitzner[SUP] 4 [/SUP], Erica Dueger[SUP] 1 3 5 [/SUP]



Affiliations
Free article

Abstract

Background: Multiple case definitions are used to identify hospitalized patients with community-acquired acute respiratory infections (ARI). We evaluated several commonly used hospitalized ARI case definitions to identify influenza cases.
Methods: The study included all patients from a population-based surveillance site in Damanhour, Egypt hospitalized for a broad set of criteria consistent with community acquired ARIs. Naso- and oropharyngeal (NP/OP) swabs were tested for influenza using RT-PCR. Sensitivity, specificity and PPV for influenza identification was compared between the 2014 WHO Severe Acute Respiratory Infection (SARI) definition (fever ?38?C and cough with onset within 10 days), the 2011 WHO SARI definition (fever ?38?C and cough with onset within 7 days), the 2006 PAHO SARI definition, the International Emerging Infections Program (IEIP) pneumonia case definition, and the International Management of Childhood Illness (IMCI) case definitions for moderate and severe pneumonia.
Results: From June 2009-December 2012, 5768 NP/OP swabs were obtained from 6113 hospitalized ARI patients; 799 (13.9%) were influenza positive. The 2014 WHO SARI case definition captured the greatest number of ARI patients, influenza positive patients and ARI deaths compared to the other case definitions examined. Sensitivity for influenza detection was highest for the 2014 WHO SARI definition with 88.6%, compared to the 2011 WHO SARI (78.2%) the 2006 PAHO SARI (15.8%) the IEIP pneumonia (61.0%) and the IMCI moderate and severe pneumonia (33.8% and 38.9%) case definitions (IMCI applies to <5 only).
Conclusions: Our results support use of the 2014 WHO SARI definition for identifying influenza positive hospitalized SARI cases as it captures the highest proportion of ARI deaths and influenza positive cases. Routine use of this case definition for hospital-based surveillance will provide a solid, globally comparable foundation on which to build needed response efforts for novel pandemic viruses.
 
Back
Top Bottom